Radiotherapy is effective in the management of rare penile metastases: Two case reports.


Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 13 11 2020
revised: 10 03 2021
accepted: 28 03 2021
pubmed: 27 4 2021
medline: 20 7 2021
entrez: 26 4 2021
Statut: ppublish

Résumé

Penile metastasization is an uncommon condition, mostly derived from primitive advanced abdominal cancers, with disabling symptoms. Palliative treatment, in reason of poor prognosis patients, is frequently surgical with destructive management. We report two cases of penile metastasis, from primitive prostatic adenocarcinoma and primitive urothelial carcinoma, effectively managed with radiation treatment at our institution. A three-dimensional conformal radiation therapy with 42Gy to the planning target volume in 14 fractions was delivered. Radiation treatment was safely delivered, with low toxicity profile and achieved adequate symptoms control without compromising genitourinary functions. Radiation therapy should be considered in management of rare penile metastases.

Identifiants

pubmed: 33896682
pii: S1278-3218(21)00051-2
doi: 10.1016/j.canrad.2021.03.004
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-483

Informations de copyright

Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

B Detti (B)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy. Electronic address: bdetti@unifi.it.

A Sardaro (A)

Interdisciplinary Department of Medicine, Nuclear Medicine Unit and Section of Radiology and Radiation Oncology, University of Bari Aldo-Moro, Bari, Italy.

V Maragna (V)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy.

M Mariotti (M)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy.

G Stocchi (G)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy.

M Roghi (M)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy.

M A Teriaca (MA)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy.

G Francolini (G)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy.

B Guerrieri (B)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy.

L Livi (L)

Radiation Oncology Unit, Azienda Ospedaliero Universitaria Careggi, l.go Brambilla 3, 50144 Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH